术前阿片类与苯二氮䓬类处方模式与非心脏手术后死亡率的关联
这项回顾性单中心人群队列研究纳入冰岛2005至2015年41 170例非心脏手术病例,分析术前6个月内阿片类和/或苯二氮䓬类处方与术后死亡及持续阿片消费的关系。结果显示,两类药物联合处方者30天死亡率(3.2% vs 1.8%)和长期死亡风险(HR 1.41)更高,且持续术后阿片消费率更高。
要点
- 术前6个月联合处方阿片类和苯二氮䓬类与30天及长期死亡率升高相关。
- 单用阿片类或苯二氮䓬类与30天死亡率无显著差异,长期死亡风险仅阿片类有统计学意义。
- 术前任一类处方均与术后持续阿片消费率升高相关。
核心结论
- 术前6个月内填写阿片类和/或苯二氮䓬类处方与短期和长期死亡率增加及持续术后阿片消费率升高相关。
- 建议这类患者早期转诊至术前门诊并进行药物优化以改善手术结局。
研究设计与样本
- 回顾性、单中心、基于人群的队列研究,纳入2005年12月12日至2015年12月31日冰岛国家医院所有18岁及以上非心脏手术患者,随访至2016年5月20日。
- 共纳入27 787例个体的41 170例非心脏手术病例,其中女性16 004例(57.6%),平均(SD)年龄56.3(18.8)岁。
- 采用倾向性评分匹配对照队列,对照为术前6个月内未填写任何一类药物处方的患者。
主要发现
- 术前仅填写阿片类处方7 460例(17.7%),仅苯二氮䓬类3 121例(7.4%),两者均填写2 633例(6.2%)。
- 与未填写任何一类处方的患者相比,仅阿片类者30天死亡率1.3% vs 1.0%(P=.23),仅苯二氮䓬类者1.9% vs 1.5%(P=.32),均无显著差异。
- 仅阿片类者长期死亡风险HR 1.12(95%CI 1.01-1.24;P=.03),仅苯二氮䓬类者HR 1.11(95%CI 0.98-1.26;P=.11)。
- 两者均填写者30天死亡率3.2% vs 1.8%(P=.004),长期死亡风险HR 1.41(95%CI 1.22-1.64;P<.001)。
- 持续术后阿片消费率:仅阿片类43%、仅苯二氮䓬类23%、两者均填写66%、均未填写12%(所有P<.001)。
关键数值与推荐
- 术前6个月内填写阿片类和/或苯二氮䓬类处方定义为暴露。
- 持续术后阿片消费定义为术后超过3个月仍填写阿片类处方。
- 合并症负担:Elixhauser合并症指数>0者比例在仅阿片类为16%、仅苯二氮䓬类为22%、两者均为21%,均未填写者为14%。
临床怎么用
- 对术前6个月内使用阿片类和/或苯二氮䓬类的患者,应考虑早期转诊至术前门诊进行药物优化。
- 关注联合使用两类药物患者的围术期死亡风险及术后持续阿片消费风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The number of patients prescribed long-term opioids and benzodiazepines and complications from their long-term use have increased. Information regarding the perioperative outcomes of patients prescribed these medications before surgery is limited. OBJECTIVE: To determine whether patients prescribed opioids and/or benzodiazepines within 6 months preoperatively would have greater short- and long-term mortality and increased opioid consumption postoperatively. DESIGN, SETTING, AND PARTICIPANTS: This retrospective, single-center, population-based cohort study included all patients 18 years or older, undergoing noncardiac surgical procedures at a national hospital in Iceland from December 12, 2005, to December 31, 2015, with follow-up through May 20, 2016. A propensity score-matched control cohort was generated using individuals from the group that received prescriptions for neither medication class within 6 months preoperatively. Data analysis was performed from April 10, 2018, to March 9, 2019. EXPOSURES: Patients who filled prescriptions for opioids only, benzodiazepines only, both opioids and benzodiazepines, or neither medication within 6 months preoperatively. MAIN OUTCOMES AND MEASURES: Long-term survival compared with propensity score-matched controls. Secondary outcomes were 30-day survival and persistent postoperative opioid consumption, defined as a prescription filled more than 3 months postoperatively. RESULTS: Among 41 170 noncardiac surgical cases in 27 787 individuals (16 004 women [57.6%]; mean [SD] age, 56.3 [18.8] years), a preoperative prescription for opioids only was filled for 7460 cases (17.7%), benzodiazepines only for 3121 (7.4%), and both for 2633 (6.2%). Patients who filled preoperative prescriptions for either medication class had a greater comorbidity burden compared with patients receiving neither medication class (Elixhauser comorbidity index >0 for 16% of patients filling prescriptions for opioids only, 22% for benzodiazepines only, and 21% for both medications compared with 14% for patients filling neither). There was no difference in 30-day (opioids only: 1.3% vs 1.0%; P = .23; benzodiazepines only: 1.9% vs 1.5%; P = .32) or long-term (opioids only: hazard ratio [HR], 1.12 [95% CI, 1.01-1.24]; P = .03; benzodiazepines only: HR, 1.11 [95% CI, 0.98-1.26]; P = .11) survival among the patients receiving opioids or benzodiazepines only compared with controls. However, patients prescribed both opioids and benzodiazepines had greater 30-day mortality (3.2% vs 1.8%; P = .004) and a greater hazard of long-term mortality (HR, 1.41; 95% CI, 1.22-1.64; P < .001). The rate of persistent postoperative opioid consumption was higher for patients filling prescriptions for opioids only (43%), benzodiazepines only (23%), or both (66%) compared with patients filling neither (12%) (P < .001 for all). CONCLUSIONS AND RELEVANCE: The findings suggest that opioid and benzodiazepine prescription fills in the 6 months before surgery are associated with increased short-and long-term mortality and an increased rate of persistent postoperative opioid consumption. These patients should be considered for early referral to preoperative clinic and medication optimization to improve surgical outcomes.
引用
- Sigurdsson MI, Helgadottir S, Long TE, et al. Association Between Preoperative Opioid and Benzodiazepine Prescription Patterns and Mortality After Noncardiac Surgery. JAMA Surg. 2019. PMID: 31215988. doi:10.1001/jamasurg.2019.1652
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。